EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Albumin Nanoparticles for Targeted Cancer Therapy: Mechanistic Insights Into Bio‐Inspired Design and Clinical Translation

L F A Anand Raj, Krithika Velmurugan, Sangeetha Baskaran, S Karthick Raja Namasivayam iD

Biotechnology and Bioengineering · 2026

DOI: 10.1002/bit.70264 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biotechnology and Bioengineering, 2026. Verfasst von L F A Anand Raj und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, St. Joseph's College of Engineering, Anna University, Chennai, Tamil Nadu, India. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles, Antineoplastic Agents, Albumins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Limitations in the efficacy and safety of conventional oncologic regimens have driven a radical reappraisal of drug delivery paradigms, prompting the emergence of albumin‐facilitated nanoscale delivery vehicles as a versatile solution to longstanding pharmacological challenges. These platforms, constructed from the abundant plasma protein, exhibit an intrinsic capacity for molecular self‐assembly, robust drug encapsulation, and selective interaction with target cell populations through both passive and active targeting mechanisms. By incorporating stimuli‐responsive coatings and programmable surface ligands, albumin‐driven nanostructures are able to synchronize drug release with the physiological and molecular context of neoplastic tissue, thereby reducing systemic toxicity and bolstering therapeutic outcomes. This study reveals the latest advances in protein nanotechnology, including scalable fabrication protocols, real‐time monitoring capabilities, and approaches to mitigate immunogenicity. The discussion further interrogates the translational landscape, addressing critical bottlenecks in clinical trial design, bioethical considerations, and the integration of patient genetic profiling for optimized treatment selection. Collectively, the evidence presented underscores the transformative potential of albumin‐mediated platforms in achieving next‐generation, patient‐centered cancer care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNanoparticlesAntineoplastic AgentsAlbuminsDrug Delivery SystemsHumansAnimals

Stichwörter der Autor:innen

cancercontrolled releasedeliverydrug targetencapsulationprotein nanoparticles

Substanzen

Antineoplastic AgentsAlbumins

Autor:innen und Institutionen

  • Department of Biotechnology, St. Joseph's College of Engineering, Anna University, Chennai, Tamil Nadu, India.
  • Centre for Applied Research, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, India.

ORCID-Profile: S Karthick Raja Namasivayam

Zitieren

APA

Anand Raj, L. F. A., Velmurugan, K., Baskaran, S., & Namasivayam, S. K. R. (2026). Albumin Nanoparticles for Targeted Cancer Therapy: Mechanistic Insights Into Bio‐Inspired Design and Clinical Translation. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70264

Vancouver

Anand Raj LFA, Velmurugan K, Baskaran S, Namasivayam SKR. Albumin Nanoparticles for Targeted Cancer Therapy: Mechanistic Insights Into Bio‐Inspired Design and Clinical Translation. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70264

BibTeX
@article{AnandRaj2026,
  author = {Anand Raj, L F A and Velmurugan, Krithika and Baskaran, Sangeetha and Namasivayam, S Karthick Raja},
  title = {Albumin Nanoparticles for Targeted Cancer Therapy: Mechanistic Insights Into Bio‐Inspired Design and Clinical Translation},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  doi = {10.1002/bit.70264}
}
Kostenlos starten →